Results
1 -
7 of
7
(Click
here to explore results)
- A novel lurasidone hydrochloride–shikimic acid co-amorphous system formed by hydrogen-bonding interaction with the retained pH-dependent solubility behavior. Yi Hu, Cuiping Jiang, Bin Li, Lijing Zhou, Renjie Xu, Yujie Guo, Yan Cao, Guosheng Cao, Shan Lu
, CrystEngComm
, 2020
, 22
, 5841
- Enhanced dissolution and oral bioavailability of lurasidone hydrochloride nanosuspensions prepared by antisolvent precipitation–ultrasonication method. Shan Lu, Pan-pan Yu, Jian-Hua He, Shuang-shuang Zhang, Yu-Long Xia, Wen-Li Zhang, Jian-Ping Liu
, RSC Adv.
, 2016
, 6
, 49052
- A novel drug–drug coamorphous system without molecular interactions: improve the physicochemical properties of tadalafil and repaglinide. Meiling Su, Yanming Xia, Yajing Shen, Weili Heng, Yuanfeng Wei, Linghe Zhang, Yuan Gao, Jianjun Zhang, Shuai Qian
, RSC Adv.
, 2020
, 10
, 565
- Investigation of the preparation, characterization, and whitening activity of co-amorphous glabridin and oxymatrine. Peiyi Liang, Yi Hu, Zhuxian Wang, Yinglin Guo, Hongkai Chen, CuiPing Jiang, Quanfu Zeng, Chunyan Shen, Yufan Wu, Li Liu, Yankui Yi, Hongxia Zhu, Zhijun Yang, Qiang Liu
, CrystEngComm
, 2023
, 25
, 6252
- Charge-assisted intermolecular hydrogen bond formed in coamorphous system is important to relieve the pH-dependent solubility behavior of lurasidone hydrochloride. Shuai Qian, Zhen Li, Weili Heng, Shujun Liang, Di Ma, Yuan Gao, Jianjun Zhang, Yuanfeng Wei
, RSC Adv.
, 2016
, 6
, 106396
- Schizophrenia: synthetic strategies and recent advances in drug design. Maria Azmanova, Anaïs Pitto-Barry, Nicolas P. E. Barry
, Med. Chem. Commun.
, 2018
, 9
, 759
- Self-gelation involved in the transformation of resveratrol and piperine from a co-amorphous system into a co-crystal system. Jiawei Han, Luyuan Li, Qian Yu, Daoyi Zheng, Yutong Song, Jianjun Zhang, Yuan Gao, Weili Heng, Shuai Qian, Zunting Pang
, CrystEngComm
, 2022
, 24
, 5733